The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Nicola.Logan.2@glasgow.ac.uk
School of Medicine, Dentistry & Nursing, General Practice & Primary Care, Wolfson Medical School Building, Gilmorehill Campus
Tyson, G. B., Jones, S., Logan, N., McDonald, M., Murcia, P. R. , Willett, B. J. , Weir, W. and Hosie, M. J. (2022) Rising SARS-CoV-2 seroprevalence and patterns of cross-variant antibody neutralization in UK domestic cats. bioRxiv, (doi: 10.1101/2022.11.18.517046)
Willett, B. J. et al. (2022) Distinct antigenic properties of the SARS-CoV-2 Omicron lineages BA.4 and BA.5. bioRxiv, (doi: 10.1101/2022.05.25.493397)
Sziemel, A. M., Hwa, S.-H., Sigal, A., Tyson, G., Logan, N., Willett, B. J. and Durcan, P. J. (2021) Development of highly potent neutralising nanobodies against multiple SARS-CoV-2 variants including the variant of concern B.1.351. bioRxiv, (doi: 10.1101/2021.04.11.439360)
Tyson, G. B., Jones, S., Logan, N., McDonald, M., Murcia, P. R. , Willett, B. J. , Weir, W. and Hosie, M. J. (2022) Rising SARS-CoV-2 seroprevalence and patterns of cross-variant antibody neutralization in UK domestic cats. bioRxiv, (doi: 10.1101/2022.11.18.517046)
Willett, B. J. et al. (2022) Distinct antigenic properties of the SARS-CoV-2 Omicron lineages BA.4 and BA.5. bioRxiv, (doi: 10.1101/2022.05.25.493397)
Sziemel, A. M., Hwa, S.-H., Sigal, A., Tyson, G., Logan, N., Willett, B. J. and Durcan, P. J. (2021) Development of highly potent neutralising nanobodies against multiple SARS-CoV-2 variants including the variant of concern B.1.351. bioRxiv, (doi: 10.1101/2021.04.11.439360)